BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16483843)

  • 1. Renal impairment: a risk factor for ischemic heart disease.
    Zoccali C
    Curr Opin Pharmacol; 2006 Apr; 6(2):221-5. PubMed ID: 16483843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical profile and management of hypertensive patients with chronic ischemic heart disease and renal dysfunction attended by cardiologists in daily clinical practice.
    Barrios V; Escobar C; Murga N; de Pablo C; Bertomeu V; Calderón A; Echarri R
    J Hypertens; 2008 Nov; 26(11):2230-5. PubMed ID: 18854765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The scope of coronary heart disease in patients with chronic kidney disease.
    Hage FG; Venkataraman R; Zoghbi GJ; Perry GJ; DeMattos AM; Iskandrian AE
    J Am Coll Cardiol; 2009 Jun; 53(23):2129-40. PubMed ID: 19497438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of drug-eluting stents on outcomes of patients with end-stage renal disease undergoing percutaneous coronary revascularization.
    Das P; Moliterno DJ; Charnigo R; Mukherjee D; Steinhubl SR; Sneed JD; Booth DC; Ziada KM
    J Invasive Cardiol; 2006 Sep; 18(9):405-8. PubMed ID: 16954577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morbidity, mortality and economic burden of renal impairment in cardiac intensive care.
    Chew DP; Astley C; Molloy D; Vaile J; De Pasquale CG; Aylward P
    Intern Med J; 2006 Mar; 36(3):185-92. PubMed ID: 16503954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic syndrome is associated with severe coronary artery disease and poor cardiac outcome in end-stage renal disease patients with acute coronary syndrome.
    Chen HH; Wu CJ; Chen YC; Tsai CS; Lin FJ; Yeh HI
    Coron Artery Dis; 2006 Nov; 17(7):593-6. PubMed ID: 17047442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diminished glomerular filtration rate as a marker of chronic kidney disease in hypertensive patients].
    Grabysa R; Cholewa M
    Pol Merkur Lekarski; 2008 Jun; 24(144):487-91. PubMed ID: 18702327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal function and outcomes in acute coronary syndrome: impact of clopidogrel.
    Keltai M; Tonelli M; Mann JF; Sitkei E; Lewis BS; Hawken S; Mehta SR; Yusuf S;
    Eur J Cardiovasc Prev Rehabil; 2007 Apr; 14(2):312-8. PubMed ID: 17446813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stage of chronic kidney disease and severity of coronary heart disease manifestation.
    Athyros VG; Katsiki N; Karagiannis A; Mikhailidis DP
    Expert Opin Pharmacother; 2012 Mar; 13(4):457-60. PubMed ID: 22332967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of oral nicorandil in patients with end-stage renal disease: a retrospective chart review after coronary angioplasty in Japanese patients receiving hemodialysis.
    Ishii H; Toriyama T; Aoyama T; Takahashi H; Yamada S; Kasuga H; Ichimiya S; Kanashiro M; Mitsuhashi H; Maruyama S; Matsuo S; Naruse K; Matsubara T; Murohara T
    Clin Ther; 2007 Jan; 29(1):110-22. PubMed ID: 17379051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary artery disease in chronic kidney disease patients: assessing the evidence for diagnosis, screening and revascularization.
    Saw J; Levin A; Gin K
    Can J Cardiol; 2004 Jun; 20(8):807-13. PubMed ID: 15229763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiorenal consideration as a risk factor for heart failure.
    Obialo CI
    Am J Cardiol; 2007 Mar; 99(6B):21D-24D. PubMed ID: 17378991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Glomerular filtration rate and cardiovascular risk: prognostic and therapeutic implications].
    Ratto E; Leoncini G; Viazzi F; Pontremoli R
    G Ital Nefrol; 2008; 25(1):21-31. PubMed ID: 18264915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal dysfunction and coronary disease: a high-risk combination.
    Schiele F
    J Nephrol; 2009; 22(1):39-45. PubMed ID: 19229817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Silent ischemia in patients on dialysis treatment].
    Cice G; Di Benedetto A; Sarubbi B; Tedesco MA; Iacono A
    Cardiologia; 1994 Sep; 39(9):629-32. PubMed ID: 7859229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal dysfunction and risk of ischemic stroke or TIA in patients with cardiovascular disease.
    Koren-Morag N; Goldbourt U; Tanne D
    Neurology; 2006 Jul; 67(2):224-8. PubMed ID: 16864812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Staging and measurement of renal function in chronic renal conditions].
    Hartmann A; Holdaas H; Os I; Hunderi OH; Hallan S; Widerøe TE; Svarstad E; Selvig K; Skjønsberg H; Toft I
    Tidsskr Nor Laegeforen; 2006 Apr; 126(9):1198-200. PubMed ID: 16670740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired renal function in acute myocardial infarction.
    Lekston A; Kurek A; Tynior B
    Cardiol J; 2009; 16(5):400-6. PubMed ID: 19753517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevalence of chronic kidney disease in community-dwelling elderly and associated cardiovascular risk factors].
    Almirall J; Vaqueiro M; Antón E; Baré ML; González V; Jaimez E; Gimeno C;
    Nefrologia; 2005; 25(6):655-62. PubMed ID: 16514906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
    Whitfield MD; Gillett M; Holmes M; Ogden E
    Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.